1672-3384
2015 Issue 6
Advance in research on anti-HCV drugs
WANG Hong-liang;CAO Shuang;China Food and Drug Administration;Center for Drug Evaluation;National Engineering Research Center for the Strategic Drug;Institute of Pharmacology and Toxicology;Academy of Military Medical Sciences;
WANG Hong-liang;CAO Shuang;China Food and Drug Administration;Center for Drug Evaluation;National Engineering Research Center for the Strategic Drug;Institute of Pharmacology and Toxicology;Academy of Military Medical Sciences;
..............page:1-5
..............page:5
Research advancement of DPP-4 inhibitors`influence on cardiovascular system and its application in Chinese type 2 diabetes patients
ZHENG Juan;CHEN Lu-lu;Wuhan Union Hospital affiliated to Tongji Medical College;Huazhong University of Science and Technology;
ZHENG Juan;CHEN Lu-lu;Wuhan Union Hospital affiliated to Tongji Medical College;Huazhong University of Science and Technology;
..............page:6-10
Literature Analysis on 41 Cases of Adverse Drug Reactions Induced by Repaglinide
WEI Jin-fei;ZHOU Liang;WANG Xiao-qing;WANG Xin-hui;ZHANG Xin;WANG Ming-mei;First Hospital Affiliated to General Hospital of PLA;
WEI Jin-fei;ZHOU Liang;WANG Xiao-qing;WANG Xin-hui;ZHANG Xin;WANG Ming-mei;First Hospital Affiliated to General Hospital of PLA;
..............page:11-14
Beraprost sodium for pulmonary arterial hypertension:A meta-analysis
TANG Hui-lin;WANG Yu-yang;YANG Yi-heng;Department of Pharmacy;Peking University Third Hospital;
TANG Hui-lin;WANG Yu-yang;YANG Yi-heng;Department of Pharmacy;Peking University Third Hospital;
..............page:15-20
Therapeutic drug monitoring of cyclosporine A in children undergoing hematopoietic stem cell transplantation
WANG Xiang-yan;ZHONG Xu-li;SONG Ze-liang;SONG Yuan;SHI Xiao-dong;Department of Pharmacy;Capital Institute of Pediatrics;Department of Hematoloy;Capital Institute of Pediatrics;
WANG Xiang-yan;ZHONG Xu-li;SONG Ze-liang;SONG Yuan;SHI Xiao-dong;Department of Pharmacy;Capital Institute of Pediatrics;Department of Hematoloy;Capital Institute of Pediatrics;
..............page:21-24
Analysis of off-label medicine use in dermatology outpatient department of China-Japan Friendslnp Hospital
ZHANG Cui-cui;ZHANG Lei;RANG Ying-zi;CUI Yuan;YANG Xiang-hu;LU Jin;Department of Pharmacy;China-Japan Friendship Hospital;
ZHANG Cui-cui;ZHANG Lei;RANG Ying-zi;CUI Yuan;YANG Xiang-hu;LU Jin;Department of Pharmacy;China-Japan Friendship Hospital;
..............page:25-29
A prospective randomized controlled study of clinical pharmacists led chronic disease management to improve clinical indicators in patients with type 2 diabetes
LI Quan-zhi;ZHEN Jian-cun;PAN Peng-yu;HUO Li-li;SHI Nan-nan;Department of Pharmacy;Beijing Jishuitan Hospital;Department of Endocrine;Beijing Jishuitan Hospital;
LI Quan-zhi;ZHEN Jian-cun;PAN Peng-yu;HUO Li-li;SHI Nan-nan;Department of Pharmacy;Beijing Jishuitan Hospital;Department of Endocrine;Beijing Jishuitan Hospital;
..............page:29-33
Study of protective effect of edaravone in treating renal injury caused by extracorporeal shock wave lithotripsy in renal calculi
HUANG Zhen;LIN Sheng-han;Central Hospital of Baoji;West Central Hospital of Hainan Prorvince;
HUANG Zhen;LIN Sheng-han;Central Hospital of Baoji;West Central Hospital of Hainan Prorvince;
..............page:34-37
Effect of Thymosin α1 on Tumor Necrosis Factor and Interleukin-6 in Children with Severe Pneumonia
TIAN Hai-zhen;HU Cui-ping;CHENG Jin-song;Depantment of Pedictrics;maternal and Child Health Hospital of Yuhang District;
TIAN Hai-zhen;HU Cui-ping;CHENG Jin-song;Depantment of Pedictrics;maternal and Child Health Hospital of Yuhang District;
..............page:38-41
Clinical Observation of Heweiguchangfang for Prevention of Delayed Diarrhea Induced by Irinotecan
YANG Lei;LIAO Hong;DENG Hao-qing;WANG Jing;Department of Gastroenterology and Traditional Chinese Medicine;458 Hospital of PLA;
YANG Lei;LIAO Hong;DENG Hao-qing;WANG Jing;Department of Gastroenterology and Traditional Chinese Medicine;458 Hospital of PLA;
..............page:42-44
Evaluation and analysis of the effect of Bifidobacterium Tetravaccine tablets combined with oral liquid of Yinzhihuang for the treatment of neonatal jaundice
HOU Hao;Maternal and Child Hospital of Hunan;
HOU Hao;Maternal and Child Hospital of Hunan;
..............page:45-47
Comprehensive curative effect evaluation on sequential therapy for eradication of helicobacter pylori infection in children
LUO Wei-yao;LIU Zhi-gang;HE Yun;HE Xiao-cheng;PENG Sheng;Foshan city maternal and child health care in pediatrics;
LUO Wei-yao;LIU Zhi-gang;HE Yun;HE Xiao-cheng;PENG Sheng;Foshan city maternal and child health care in pediatrics;
..............page:48-51
A clinical analysis on pegaspargase with radiochemotherapy for patients with nasal NK/T cell lymphoma
XIANG Yong-sheng;XU Xiao-dong;WANG Long;JIANG Rui;Department of Hematology;The First People`s Hospital of Jingmen;Department of Cardiology;The First People`s Hospital of Jingmen;
XIANG Yong-sheng;XU Xiao-dong;WANG Long;JIANG Rui;Department of Hematology;The First People`s Hospital of Jingmen;Department of Cardiology;The First People`s Hospital of Jingmen;
..............page:51-53
A retrospective analysis of 1701 cases of orthopedic clinical pharmacists involved in clinical drug treatment
ZHANG Wei;SONG Xia;GUAN Shang-Wei;LI Jing;MAO Lu;XING Ying;YANG Yuan;CAO Yu;ZHEN Jian-Cun;Beijing Jishuitan Hospital;Lanzhou University Second Hospital;The Affiliated Tumor Hospital of Harbin Medical University;
ZHANG Wei;SONG Xia;GUAN Shang-Wei;LI Jing;MAO Lu;XING Ying;YANG Yuan;CAO Yu;ZHEN Jian-Cun;Beijing Jishuitan Hospital;Lanzhou University Second Hospital;The Affiliated Tumor Hospital of Harbin Medical University;
..............page:54-58
Effect of valproic on biochemical and routine blood test of hospitalized patients
AN Sheng-nan;YANG Li-ping;SHI Ai-xin;HU Xin;Shenyang Pharmaceutical University;Department of Pharmacy;Beijing Hospita;Ministry of Public Health;Key Laboratory of Drug Clinical Risk and Individual Applications Assessment in Beijing;
AN Sheng-nan;YANG Li-ping;SHI Ai-xin;HU Xin;Shenyang Pharmaceutical University;Department of Pharmacy;Beijing Hospita;Ministry of Public Health;Key Laboratory of Drug Clinical Risk and Individual Applications Assessment in Beijing;
..............page:59-63
Analysis of 89 cases of ADRs caused by cephamycin
SU Ye;Department of Pharmacy;Beijing Chaoyang Hospital affiliated to Capital Medical University;
SU Ye;Department of Pharmacy;Beijing Chaoyang Hospital affiliated to Capital Medical University;
..............page:64-67
Investigation and Analysis of Off-label usage of Ranibizumab
LI Li;HAN Fu-rong;WANG Jia-wei;Department of Pharmacy;Beijing Tongren Hospital;Capital Medicine University;
LI Li;HAN Fu-rong;WANG Jia-wei;Department of Pharmacy;Beijing Tongren Hospital;Capital Medicine University;
..............page:68-70
Comparative study on supervision policy of drugs for clinical trials between China and oversea
CONG Luo-luo;ZHANG Juan;LIU Wei;Beijing Municipal Drug Administration;
CONG Luo-luo;ZHANG Juan;LIU Wei;Beijing Municipal Drug Administration;
..............page:71-76
Pharmaceutical Care for antimicromals related encephalopathy in a renal failure patient
DONG Yue;ZHANG Chao;HU Xin;Department of Administration and Clinical Pharmacy;Peking University School of Pharmaceutical Sciences;Department of Pharmacy;Beijing Hospital;Department of Pharmacy;Peking University Third Hospital;
DONG Yue;ZHANG Chao;HU Xin;Department of Administration and Clinical Pharmacy;Peking University School of Pharmaceutical Sciences;Department of Pharmacy;Beijing Hospital;Department of Pharmacy;Peking University Third Hospital;
..............page:77-81
Probable amlodipine-induced systemic involuntary wiggling
YANY Jiu-yi;GU Jian;People’s Hospital of Peking University;
YANY Jiu-yi;GU Jian;People’s Hospital of Peking University;
..............page:81-84
A First-in-class angiotensin II receptor-neprilysin inhibitor(ARNi)Entresto(sacubitril/valsartan)
WANG Hong-liang;WANG Huan;Center For Drug Evaluation;CFDA;National Engineering Research Center for the Strategic Drug;Institute of Pharmacology & Toxicology of AMMS;
WANG Hong-liang;WANG Huan;Center For Drug Evaluation;CFDA;National Engineering Research Center for the Strategic Drug;Institute of Pharmacology & Toxicology of AMMS;
..............page:85-88
..............page:88
..............page:89
..............page:89-90
..............page:90
quan qiu kang bing gan yao wu shi chang zong guan
zhou xin bo ;
zhou xin bo ;
..............page:91
kang zhong liu yao wu pd-1 yi zhi ji
zhou xin bo ;
zhou xin bo ;
..............page:92